Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abstract, arbitration, atezolizumab, burden, carcinoma, checkpoint, Clay, Counsel, description, Dobmeier, dose, Drachman, encounter, entirety, Eric, ESMO, formulation, forward, insufficient, invite, Jean, Jonathan, Liu, metastatic, molocule, move, notwithstanding, oral, partner, pracinostat, President, properly, repeat, restated, sBLA, secondary, seventeen, showed, Siegall, supplemental, text, urothelial, Vice
Removed:
aimed, commit, curb, exercising, inclusive, initiate, offsite, performing, prioritize, shared
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view